SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2017 Tampa, FL
Activity/Course #:
: 06.24.17PC

Cost:
: Free
Release/Start Date:
: Jun 24 2017
Expiration Date:
: Jun 24 2017
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 6.0 hours
Credit(s):
: 6.0 AMA PRA Category I Credit(s)
6.0 AANP Contact hour(s) which includes 2.75 pharmacology hour(s)
Hardware/Software Requirements:
(Chrome not supported at this time)

Saturday, June 24, 2017

Tampa Marriott Waterside Hotel
700 South Florida Avenue
Tampa, FL 33602
(813) 221-4900

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

A self-garage parking rate of $10.00 is available across the street from the hotel. A $15.00 discounted valet parking rate is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $139 per night at the Tampa Marriott Waterside Hotel. To reserve your room at this rate call 1-813-221-4900 and ask for the NACE room block by June 9, 2017.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Describe the role of the kidney in glucose metabolism in health and disease; Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations; Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options; Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.

  2. Explain the epidemiology and pathogenesis of migraine headaches; Describe ways by which migraine can be diagnosed by PCPs; Discuss clues which may differentiate migraine from “secondary headache” disorders; and outline preventative, acute, abortive and rescue interventions for migraine.

  3. Describe the typical clinical presentation of a patient with possible idiopathic pulmonary fibrosis (IPF); Discuss the diagnostic approach to a patient with suspected IPF; Discuss and contrast the available pharmacotherapeutic options for patients with IPF; Discuss and contrast the available nonpharmacotherapeutic options for patients with IPF.

  4. List 2017 Quality Measures for the use of statin therapy for the prevention and treatment of cardiovascular disease; Explain the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction; Discuss ACC guidelines on the role of non-statin therapies in the management of atherosclerotic cardiovascular disease; Employ guideline-directed treatment strategies for primary and secondary prevention of cardiovascular disease in high-risk patient populations.

  5. Discuss the discovery and components of the endocannabinoid system; Review potential therapeutic uses and potential adverse effects; Discuss qualifying conditions for medical cannabis use in various states; Review the concerns and considerations of clinicians.
 
Agenda*

7:30-8:00

  Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Jack Kravitz, MD
8:10-9:20  

Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management: Evolving Treatment Strategies
Jeff Unger, MD, ABFM, FACE

9:20-10:30   Brainstorm: A Symposium on Migraine Treatment and Management
Jeff Unger, MD, ABFM, FACE
10:30-10:50   Break
10:50-12:00   Idiopathic Pulmonary Fibrosis: Defining the Role of the Primary Care Clinician in Diagnosis and Therapy 
David J. Lederer, MD, MS
12:00-1:10  

Lunch
Presentation Theater: Awaken a Transformation in Type 2 Diabetes Management
(CME not offered)

1:10-2:20   New Agents, New Options, and Expanded Potential In Lipid Management: Integrating The Data Into Practice
Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH
2:20-3:30  

Cannabinoids: Medical Implications
Richard J. Schrot, MD

   3:30-3:45 Program Summary and Closing Remarks
Jack Kravitz, MD
 
*Agenda subject to change.
 
Faculty
Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA
 
Jack Kravitz, MD
Family Practice - Geriatrics
Coral Springs, FL
 
David J. Lederer, MD, MS
Associate Professor of Medicine & Epidemiology
Co-Director, Interstitial Lung Disease Program
Columbia University Medical Center
New York, NY
 
Richard J. Schrot, MD
Affiliate Associate Professor
Department of Family Medicine
University of South Florida College of Medicine
Tampa, FL
 
Jeff Unger, MD, ABFM, FACE
Director, Unger Primary Care Medical Group
Rancho Cucamonga, CA
 
Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6 contact hours of continuing education (which includes 2.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Emerging Challenges in Primary Care: 2017 is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.; and an educational grant from Sanofi US and Regeneron Pharmaceuticals.